| Literature DB >> 34916474 |
Ye Yao1,2,3, Xin-Jian Qiu2, Dong-Sheng Wang2, Jie-Kun Luo2, Tao Tang2, Yun-Hui Li2, Chun-Hu Zhang2, Hao Liu4, Lu Zhou2, Lin-Lin Zhao1.
Abstract
Large numbers of microbes can be present in seminal fluid, and there are differences in the semen microbiota between normal and abnormal semen samples. To evaluate the semen microbiota in patients with leukocytospermia, 87 seminal fluid samples, including 33 samples with a normal seminal leukocyte count and 54 samples with leukocytospermia, were obtained for a cross-sectional analysis. Twenty samples with a normal seminal leukocyte count had normal sperm parameters (Control group), and 13 samples with a normal seminal leukocyte count were from asthenozoospermia patients (Ast group). However, 32 samples with leukocytospermia were from asthenozoospermia patients (LA group), and only 22 samples with leukocytospermia had normal sperm parameters (Leu group). The 16S ribosomal RNA (rRNA) gene sequencing method was used to sequence the microbiota in the seminal fluid, and multiple bioinformatics methods were utilized to analyze the data. Finally, the results showed that the worse sperm parameters were observed in the leukocytospermia-related groups. Semen microbiota analysis found that there was increased alpha diversity in the leukocytospermia-related groups. Firmicutes, Proteobacteria, Actinobacteria, and Bacteroidetes were the primary phyla in the seminal fluid. Two microbiota profiles, namely, Lactobacillus-enriched and Streptococcus-enriched groups, were identified in this study. The majority of the samples in the groups with a normal seminal leukocyte count could be categorized as Lactobacillus-enriched, whereas the majority of the leukocytospermia samples could be categorized as Streptococcus-enriched. Our study indicated that males with leukocytospermia have worse sperm parameters and a different semen microbiota composition compared to males with a normal seminal leukocyte count.Entities:
Keywords: 16S rRNA gene sequencing; asthenozoospermia; leukocytospermia; semen microbiota; sperm motility
Mesh:
Year: 2022 PMID: 34916474 PMCID: PMC9295480 DOI: 10.4103/aja202172
Source DB: PubMed Journal: Asian J Androl ISSN: 1008-682X Impact factor: 3.054
Sperm parameters in the nonleukocytospermia and leukocytospermia groups
|
|
|
| ||
|---|---|---|---|---|
|
|
| |||
|
|
|
|
| |
| Patient, | 304 (66.1) | 156 (33.9) | 255 (36.4) | 446 (63.6) |
| Leukocytospermia (×106 ml−1) | 0.70 (0.50–0.90) | 0.73 (0.60–0.90) | 1.40 (1.10–1.50)ab | 1.68 (1.20–1.70)ab |
| Age (year) | 30.6 (28.0–33.8) | 30.2 (28.0–33.0) | 30.0 (27.0–33.0) | 30.5 (28.0–33.0) |
| Semen volume (ml) | 3.0 (1.5–4.5) | 3.1 (2.0–4.0) | 3.0 (2.0–4.0) | 3.0 (1.5–4.0) |
| Sperm concentration (×106 ml−1) | 195.6 (140.8–237.9) | 106.7 (61.8–140.8)a | 177.4 (132.8–207.2)ab | 96.4 (64.0–122.2)ab |
| Progressive sperm motility (%) | 44.0 (37.4–49.3) | 24.6 (21.6–29.6)a | 39.6 (34.6–43.2)ab | 22.7 (18.2–28.5)ab |
| Total sperm motility (%) | 67.5 (60.3–74.7) | 43.1 (38.6–50.2)a | 61.9 (55.1–68.5)ab | 40.5 (35.0–48.0)ab |
| Sperm acrosin activity (×106 µIU−1) | 108.0 (95.3–118.3) | 75.0 (56.9–91.2)a | 96.6 (83.8–106.9)ab | 63.7 (50.8–72.0)ab |
aThe Ast, Leu or LA group compared to the Control group, P<0.001; bThe Leu or LA group compared to the Ast group, P<0.001. Data are shown as median (IQR). Ast group: asthenozoospermia patients with a normal seminal leukocyte count; Leu group: patients with leukocytospermia and normal sperm parameters; LA group: asthenozoospermia patients with leukocytospermia; IQR: interquartile range
Detailed patient information for sperm microbiota analysis
|
|
|
|
| |
|---|---|---|---|---|
| Number | 20 | 13 | 22 | 32 |
| Age (year), median (IQR)* | 29.0 (27.3–30.0) | 31.2 (29.0–33.5) | 29.3 (26.8–30.3) | 32.4 (28.3–37.8) |
| Semen volume (ml), median (IQR) | 3.4 (2.1–4.9) | 3.8 (3.0–4.5) | 3.8 (3.0–5.0) | 3.8 (3.0–4.5) |
| WBC (109 l−1), median (IQR)* | 7.0 (6.0–7.9) | 6.8 (5.8–7.5) | 7.0 (5.4–8.2) | 6.8 (5.6–7.0) |
| Hemoglobin (g l−1), median (IQR)* | 147.4 (134.8–160.2) | 149.4 (137.3–157.5) | 147.5 (130.0–159.0) | 151.4 (145.0–161.0) |
| PLT (1012 l−1), median (IQR)* | 222.6 (192.5–253.3) | 223.5 (201.5–248.8) | 234.7 (201.5–248.8) | 219.3 (200.0–234.0) |
| Smoking ratio (%)* | 25.0 | 30.7 | 27.3 | 25.8 |
*No significant difference between each group. LA group: asthenozoospermia patients with leukocytospermia; IQR: interquartile range; WBC: white blood cell; PLT: pallet